-
WES STREETING: Brave men like Sir Chris Hoy have spoken out about the diagnosis no one wants to hear. Now the Government must act on their words - and end needless prostate cancer deaths
09 Apr 2025 03:41 GMT
… to raise awareness about prostate cancer. The UK National Screening … all the evidence for prostate cancer screening programmes, including targeted … , speedy diagnosis and rapid treatment. Some 80,000 suspected … catch cancer earlier and treat it faster. And it …
-
Major Cost Savings On Top Cancer Drugs With India-Approved Alternatives
09 Apr 2025 04:53 GMT
… drugs that adhere to strict international standards. These medications … making ongoing treatment significantly more … financial burden on prostate cancer patients.
Osimertinib ( … pharmacies, primarily in India. The platform offers deep discounts on medications …
-
PROSTOX Ultra Reliably Predicts Long-Term Radiation AEs in Prostate Cancer
08 Apr 2025 23:30 GMT
… (RT) for prostate cancer prior to initiating treatment, according to results … news release from the drug’s developer, MiraDx.2 … 3 MIRAGE trial enrolled 148 patients with prostate cancer to receive … toxicity that could require medication and impact quality of …
-
Investigating the Prognostic Utility of GSTP1 Promoter Methylation in Prostate Cancer - Beyond the Abstract
08 Apr 2025 21:27 GMT
… making treatment outcomes highly successful. However, some men develop aggressive prostate cancer even … Prostate Cancer: Post Hoc Analyses of Data from a Phase 3 Trial … epigenetic biomarkers for prostate cancer mortality. Clin Transl Med. 2022;12(10 …
-
Pobel Translates PEACE-1 Trial Results Into Clinical Practice for mCSPC
08 Apr 2025 23:41 GMT
… of the PEACE-1 trial (NCT01957436) support the … treatment of patients with low-volume metastatic castration-sensitive prostate cancer … main findings from the trial revealed that in the … novo metastatic castration-sensitive prostate cancer (PEACE-1): a …
-
Optimizing Radiotherapy QOL for Advanced Prostate Cancer Populations
08 Apr 2025 14:00 GMT
Although outcomes for patients with low-risk or early-stage prostate cancer appear to be “good,” ongoing work seeks to improve treatment for those with advanced or potentially metastatic disease, according to Curtiland Deville Jr., MD.
Deville Jr. spoke …
-
Deep Bio’s AI Algorithm Demonstrates Significant Prognostic Advancements in Prostate Cancer Study
08 Apr 2025 13:00 GMT
– AI-derived tumor volume metrics enhance prognostic prediction over traditional pathology methods
SEOUL, SOUTH KOREA, April 8, 2025 /EINPresswire.com/ -- Deep Bio, a leader in AI-powered digital pathology, announced the publication of a …
-
Study of persistence and adherence to ADT in prostate cancer: relugolix, degarelix, and GnRH agonists in the US.
08 Apr 2025 11:49 GMT
… ADT), a key treatment for advanced prostate cancer, lowers testosterone levels … . A large clinical trial (phase III) showed … on treatment (persistence) and take their medication as … Montreal, Quebec, Canada., Sumitomo Pharma America, Inc, Marlborough, …
-
SpaceOAR hydrogel complications in prostate cancer radiotherapy: a pictorial review.
08 Apr 2025 11:49 GMT
… the United States Food and Drug Administration (FDA), the rectal hydrogel spacer … in radiation therapy protocols for prostate cancer patients. The biodegradable hydrogel creates …
-
Micro-ultrasound is easier, more affordable and just as reliable as MRI in diagnosing prostate cancer
08 Apr 2025 06:29 GMT
… method of diagnosis for prostate cancer patients, making the procedure … patients suspected of having prostate cancer in the United … trial was stopped due to early success. Serious cancer requiring treatment … participate in a clinical trial.”
Next steps for the …
About
© 1995-2025